Evaxion Biotech A/S (EVAX) Social Stream
EVAXION BIOTECH A (EVAX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EVAX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-03 | 3 | $21 | $18 | $19 | $0.749 | 2436.72% |
| 2022-07-18 | 3 | $21 | $16 | $18.333 | $0.749 | 2347.66% |
| 2022-08-11 | 3 | $18 | $16 | $17 | $0.749 | 2169.69% |
| 2022-08-12 | 2 | $18 | $16 | $17 | $0.749 | 2169.69% |
| 2022-11-15 | 2 | $16 | $15 | $15.5 | $0.749 | 1969.43% |
| 2022-11-17 | 3 | $15 | $11 | $13 | $0.749 | 1635.65% |
| 2023-03-31 | 2 | $7 | $7 | $7 | $0.749 | 834.58% |
| 2023-04-28 | 3 | $15 | $7 | $11 | $0.749 | 1368.62% |
| 2023-08-23 | 2 | $15 | $7 | $11 | $0.749 | 1368.62% |
The Trend in the Analyst Price Target
EVAX's average price target has moved down $4.5 over the prior 40 weeks.
EVAX reports an average of 746.66% for its upside potential over the past 145 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 3 | 15 | 7 | 11 | 1.13 | 873.45% |
| 2023-04-28 | 3 | 15 | 7 | 11 | 1.26 | 773.02% |
| 2023-04-28 | 2 | 15 | 7 | 11 | 1.26 | 773.02% |
| 2023-06-05 | 2 | 15 | 7 | 11 | 1.53 | 618.95% |
| 2023-08-23 | 2 | 15 | 7 | 11 | 0.98 | 1022.45% |
EVAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 39 weeks, EVAX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, EVAXION BIOTECH A's upside potential (average analyst target price relative to current price) is higher than 984% of them.
- EVAXION BIOTECH A's number of analysts covering the stock is higher than 50.85% of all US stocks.
- EVAX has a lower variance in analysts' estimates than -114.65% of Healthcare stocks.
- In terms of how EVAXION BIOTECH A fares relative to Healthcare stocks, note that its average analyst price target is greater than 248.85% of that group.
In the Pharmaceutical Products industry, TCRX, INAB, and PMCB are the three stocks most similar to EVAXION BIOTECH A regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EVAX using the data that counts. Try POWR Ratings for free.